These findings collectively suggest that ZY13 interacts with the AXL-SOCS negative regulation pathway of type I IFN signaling during ZIKV infection and thus enhancing the host’s immune response to ZIKV infection. The gene discussed is AXL; the disease is Zika virus infectious disease.